Latest Medtech News
CoreMap has secured $37 million in an oversubscribed Series C financing round led by Medtronic to accelerate the development and commercialization of its next-generation atrial fibrillation (AFib) mapping platform.
The company develops a high-density electrophysiology mapping system and advanced data analytics platform that provides physicians with more precise electrical activation data to guide AFib ablation procedures, aiming to improve treatment accuracy and patient outcomes.
The funding highlights growing confidence in CoreMap's technology and will support its next phase of growth and bring its data-driven mapping platform closer to market.
“The successful completion of this financing is a significant milestone for CoreMap,” said Sarah Kalil, CEO and co-founder of CoreMap. “This investment provides the resources to accelerate CoreMap’s next-generation AFib mapping platform’s time to market.”
